Obesity Clinical Trial
Official title:
Effects of Stevia on Satiety and Eating Attitudes in Healthy, Overweight and Obese Adults: A Pilot Study
The purpose of this study is to test the effects that three different types of sweeteners have on food intake, hunger and satiety levels, as well as insulin and glucose measures. The study of whether food or beverages containing Stevia influence food intake to a greater extent than food or beverages sweetened with Aspartame or Sucrose. Also, examining whether taste preference and taste sensitivity influence food intake.
Expected time in this study will be approximately 24 hours spread over the course of one
initial screening visit and three test days during which you complete food tests at the
Pennington Center.
Screening visit (Duration is 3 hours)
- You will initially be asked to fill out psychological questionnaires to assess your
eating habits, food cravings, and preference for foods (i.e., tea and crackers with
cream cheese) that will be provided to you in this study.
- You will also be asked to complete two taste tests during this visit. The first taste
test will be sodium chloride (table salt) followed by PROP (an extremely low dose of
hyperthyroid medication) sodium chloride (table salt).
- You will be required to provide a blood sample (19 mL or 1.3 tablespoons) to check
glucose and insulin levels.
- If you are selected to be a participant for this study, you will receive a brief
medical evaluation during which you will be weighed, your height will be measured, and
your pulse and blood pressure will be taken. You will be interviewed about your medical
history and potential obstacles for completing the study. If you are female, a brief
interview will be conducted to determine your menstrual cycle phase. Total length of
time will be approximately three hours for the screening visit.
First Food Test Day (Duration is 7- 9 hours. You'll arrive after having fasted for 12 hrs.)
For females, all test meal days will be scheduled during their luteal phase. • Breakfast:
During your first food test day, you will be asked to come to the Pennington Center at any
time between the hours of 7:00 A.M. - 8:30 A.M. and consume a standard breakfast of
Cheerios, milk, orange juice, toast, butter, and jelly. You will then be free to leave but
will be asked to return 3.5 hours later. When your return, you will be sent to our inpatient
unit for a blood draw, which will test your level of insulin and glucose (total of 25 mL or
1.67 tablespoons). You will then be asked to rate your appetite on a computer using a visual
analog scale (VAS). After completing these VAS ratings, you will be provided with an
appetizer of 5 ounces of cold tea and 6 crackers with cream cheese. Both the tea and the
cream cheese will be sweetened with one of the following sweeteners: Aspartame, Sucrose, or
Stevia. After consuming this appetizer, you will be asked to complete another set of VAS
ratings, which again ask you about your appetite, as well as the sweetness of the appetizer.
Test times will be constant for all visits. Approximately twenty minutes after consuming
this appetizer, your insulin and glucose levels will again be tested and you will complete
another set of VAS ratings before your lunch meal. You will be required to consume breakfast
at the same time for all three visits. For example, if you come at 7:00 A.M. on your first
test day, you will be required to come in at 7:00 A.M. on your next two test days.
• Lunch: After completing VAS ratings before lunch, you will be provided with a lunch
consisting of sandwiches, chips, and cookies. Your lunch meal will be served approximately 4
hours after your breakfast meal. Your eating behavior may be monitored by weight of the food
consumed and/or by video camera/tape. You may eat as much or as little of the lunch as you
wish.
• After Lunch: After you finish your lunch meal, you will be asked to complete post meal VAS
ratings. Your insulin and glucose will be measured on the three occasions after lunch: 30
minutes after lunch, one hour after lunch, and two hours after lunch for a total of 5 blood
draws (total of 25 mL or 1.67 tablespoons). You will also be asked to complete VAS ratings
30 minutes after lunch, and every hour for the next four hours. You will spend the afternoon
at the Pennington center to ensure that blood draws and VAS ratings occur at the appropriate
time intervals. During the afternoon you will be free to read, do paperwork brought from
home or work, or watch movies that will be provided to you by the Center.
• Dinner:
Four hours after the test lunch, you will be provided with another appetizer of 5 ounces of
cold tea and crackers with cream cheese. Both the tea and the cream cheese will be sweetened
with one of the following sweeteners: Stevia, sucrose, or Aspartame. You will complete VAS
ratings before and after this appetizer, as well as before and after your dinner meal (4.5
hours after lunch), during which you will be instructed to eat as much or as little of any
of the items presented as you want. Your eating behavior may be monitored by weight of the
food consumed and/or by video camera/tape. After you complete VAS questions after the
evening meal, you will have fulfilled the requirements of the first food test day. However,
you will be asked not to consume any food or caloric beverages for three hours following
your dinner meal. You will be asked to report any adverse events from this day at this
visit.
Second Food Test Day (Duration is 7-9 hours. You'll arrive after having fasted for 12 hrs.)
• On your second food test day, you will complete the same procedures and meal tests as you
did during the first food test day. However, the type of sweetener used in your tea and
crackers with cream cheese will differ from the type of sweetener you received on your first
food test day. You will be asked to report any adverse events from this day, as well as
previous visits, at this visit.
Third Food Test Day (Duration is 7-9 hours. You'll arrive after having fasted for 12 hrs.)
• On your third food test day, you will complete the same procedures and meal tests as you
did during your two previous food test days. However, the type of sweetener used in your tea
and crackers with cream cheese will differ from the type of sweetener you received on
previous visits. You will also be asked to report any adverse events from this day, as well
as previous visits, at this visit. We will also follow up by phone regarding adverse events
following your third visit. Table 1 presents a schedule of the procedures that will take
place at each of the study visits.
;
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject)
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |